Colgate-Palmolive
(NYSE:CL)
$86.405
0.235[0.27%]
Last update: 11:14AM Get Real Time Here
The dividend Ex-Date is in 3 days
Q1 2024 Earnings in 10 days from now on Fri Apr 26th, before the market open
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
62.5%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
40
0100

Colgate-Palmolive Stock (NYSE:CL), Quotes and News Summary

Colgate-Palmolive Stock (NYSE: CL) stock price, news, charts, stock research, profile.

Open$86.560
Close-
Volume / Avg.725.573K / 4.594M
Day Range86.235 - 86.730
52 Wk Range67.620 - 90.370
Market Cap$71.024B
P/E Ratio31.108
Dividend Yield2.320%
ExchangeNYSE
RSI
42
Short Interest
1.43%
Days to Cover3.41

Recent News

Here's Where To Buy Legal Weed: New Stores Launching Cannabis Sales Ahead Of 4/20, Part 1
Cannabis sales in Illinois seem to be thriving. In 2023, the licensed cannabis retailers sold more than $1.6 billion worth of cannabis, marking the third consecutive year of substantial growth in this sector. As a result, the burgeoning market will continue to expand in 2024. MariMed announced earlier this month the opening of its permanent and much "bigger" Thrive dispensary in Casey. As talks around possible recreational legalization heat up in Florida, several companies expanded their retail footprints statewide. Three cannabis companies opened store in the state, including Trulieve, Green Thumb and AYR Wellness.As New Jersey is paving its way toward reaching $1 billion in cannabis sales in 2024, two businesses recently opted to launch cannabis sales, including C3 Industries and Holistic Re-Leaf. Pennsylvania cannabis patients can make their purchases at two new storefronts, by PharmaCann Inc.and Cresco Labs.
Jelena Martinovic
Colgate-Palmolive Raises Dividend By 4%, Increase To Be Effective In Q2
Colgate-Palmolive (NYSE: CL) boosts dividend by 4% effective Q2 2024, aiming for net sales growth and mid to high-single-digit EPS growth in FY24.
Nabaparna Bhattacharya
Cannabis Co. Cresco Nearly Doubles Adjusted EBITDA YoY To $54.8M In Q4, Narrows Loss In 2023
Cresco Labs announced on Wednesday financial and operating results for the fourth quarter and year ended Dec. 31, 2023.The Chicago-based cannabis giant behind Sunnyside dispensaries reported net revenues of $188.2 in the fourth quarter, decreasing from $199.6 million in the same quarter of last year. That's down 2% year-over-year. Cresco also reported a net income of $4.9 million for the fourth quarter compared to a $180.6 million net loss in the prior year's period and $133.4 million in the prior quarter as well as achieving positive adjusted EBITDA of $54.8 million, up from $29.6 million in the prior year's period.
Jelena Martinovic
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
4
2
Jan
1
Mar
3
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.9
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Colgate-Palmolive Co.
Sector
Consumer Staples
Industry
Household Products
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product ...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CL
KMB

FAQ

Q

How do I buy Colgate-Palmolive (CL) stock?

A

You can purchase shares of Colgate-Palmolive (NYSE: CL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Colgate-Palmolive's (CL) competitors?

A

Other companies in Colgate-Palmolive’s space includes: Kimberly-Clark (NYSE:KMB), WD-40 (NASDAQ:WDFC), Spectrum Brands Holdings (NYSE:SPB), Procter & Gamble (NYSE:PG) and Central Garden & Pet (NASDAQ:CENT).

Q

What is the target price for Colgate-Palmolive (CL) stock?

A

The latest price target for Colgate-Palmolive (NYSE: CL) was reported by Citigroup on Tuesday, April 16, 2024. The analyst firm set a price target for 100.00 expecting CL to rise to within 12 months (a possible 15.73% upside). 32 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Colgate-Palmolive (CL)?

A

The stock price for Colgate-Palmolive (NYSE: CL) is $86.405 last updated Today at April 16, 2024 at 11:14 AM EDT.

Q

Does Colgate-Palmolive (CL) pay a dividend?

A

The next Colgate-Palmolive (CL) dividend date is projected to be Friday, April 19, 2024.

Q

When is Colgate-Palmolive (NYSE:CL) reporting earnings?

A

Colgate-Palmolive’s Q1 earnings are confirmed for Friday, April 26, 2024.

Q

Is Colgate-Palmolive (CL) going to split?

A

There is no upcoming split for Colgate-Palmolive.

Q

What sector and industry does Colgate-Palmolive (CL) operate in?

A

Colgate-Palmolive is in the Consumer Staples sector and Household Products industry. They are listed on the NYSE.

People Also Watch